Kirkland & Ellis represented Wind Point Partners in the deal. Wind Point Partners, a leading Chicago-based private equity firm, announced the closing of its latest fund,...
Wind Point Partners X’s Closing at $2.3 Billion Hard Cap
BridgeBio Pharma’s $750 Million Non-Dilutive Debt Financing
Latham & Watkins represented BridgeBio in the transaction. BridgeBio Pharma (Nasdaq: BBIO) (BridgeBio or the Company), a commercial-stage biopharmaceutical company focused on genetic diseases and cancers, executed a...